The use of fingerprint readers/Iris scanners to reduce default rate of TB treatments
Main beneficiary countries:India - Cambodia - Afghanistan - Tanzania
Country of origin: India
Healthcare themes targeted
Stage of development:
Area where initiative is utilised
Initiative start date
Tuberculosis patients tend to stop taking their medication as the treatment progresses, especially when they start feeling better and the symptoms disappear. This can be fatal since them dropping out of the program can result in Multi-drug-resistant tuberculosis (MDR-Tb) and then subsequently extensively drug-resistant tuberculosis (XDR-TB).
With the proposed solution, we have reduced default rate from 21% to 3%.
Patient monitoring and medical data
30000 Number of beneficiaries since launch
15000 Number of users per Year
Academic entities: Universities, research laboratories, etc.